Latest News in the pharma Industry

Policy & Regulation

Lilly's Cyramza (Ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy

Lilly's Cyramza (Ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy

23 Apr 2014

Read more 
FDA Approves Merck’s Ragwitek (Short Ragweed Pollen Allergen Extract) Sublingual Tablet

FDA Approves Merck’s Ragwitek (Short Ragweed Pollen Allergen Extract) Sublingual Tablet

18 Apr 2014

Read more 
European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Herceptin Identified

European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Herceptin Identified

17 Apr 2014

Read more 
Boehringer Ingelheim and Eli Lilly and Company Announce NDA Filing in the US for the Combination Tablet of Empagliflozin and Linagliptin

Boehringer Ingelheim and Eli Lilly and Company Announce NDA Filing in the US for the Combination Tablet of Empagliflozin and Linagliptin

16 Apr 2014

Read more 
Rx-360 Summary of the EU GDP Questions and Answers

Rx-360 Summary of the EU GDP Questions and Answers

11 Apr 2014

Read more 
BMS Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C

BMS Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C

9 Apr 2014

Read more 
FDA Approves New Hand-Held Auto-Injector to Reverse Opioid Overdose?

FDA Approves New Hand-Held Auto-Injector to Reverse Opioid Overdose?

4 Apr 2014

Read more 
Hikma Announces Successful Resolution to US FDA Warning Letter at Eatontown Facility

Hikma Announces Successful Resolution to US FDA Warning Letter at Eatontown Facility

4 Apr 2014

Read more 
FDA Approves First Sublingual Allergen Extract for the Treatment of Certain Grass Pollen Allergies?

FDA Approves First Sublingual Allergen Extract for the Treatment of Certain Grass Pollen Allergies?

3 Apr 2014

Read more 
FDA Advisory Committee Recommends Approval of Afrezzar, MannKind Corporation's Investigational Drug to Treat Diabetes

FDA Advisory Committee Recommends Approval of Afrezzar, MannKind Corporation's Investigational Drug to Treat Diabetes

3 Apr 2014

Read more 
FDA Approves Biogen Idec's ALPROLIXT

FDA Approves Biogen Idec's ALPROLIXT

31 Mar 2014

Read more 
Rx-360 Summary of FDA's Guidance on Allowable Fill Volume Excesses in Vials

Rx-360 Summary of FDA's Guidance on Allowable Fill Volume Excesses in Vials

26 Mar 2014

Read more